Siemens Fonds Invest GmbH Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Siemens Fonds Invest GmbH raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 795.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,818 shares of the medical equipment provider's stock after purchasing an additional 127,753 shares during the period. Intuitive Surgical accounts for 2.9% of Siemens Fonds Invest GmbH's holdings, making the stock its 6th biggest holding. Siemens Fonds Invest GmbH's holdings in Intuitive Surgical were worth $75,067,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BridgePort Financial Solutions LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at $330,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $167,943,000. Employees Retirement System of Texas increased its position in shares of Intuitive Surgical by 16.2% during the fourth quarter. Employees Retirement System of Texas now owns 8,346 shares of the medical equipment provider's stock worth $4,356,000 after acquiring an additional 1,165 shares in the last quarter. Brucke Financial Inc. bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $208,000. Finally, Bernard Wealth Management Corp. bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $56,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on ISRG shares. Truist Financial decreased their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Robert W. Baird decreased their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Evercore ISI decreased their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Finally, Royal Bank of Canada decreased their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $596.05.

Intuitive Surgical Stock Performance

ISRG traded down $4.61 during midday trading on Friday, reaching $551.14. The company had a trading volume of 2,091,011 shares, compared to its average volume of 1,647,905. The stock has a market cap of $197.54 billion, a PE ratio of 85.98, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12-month low of $396.48 and a 12-month high of $616.00. The business has a 50-day moving average price of $516.44 and a two-hundred day moving average price of $538.53.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the previous year, the company earned $1.50 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 3,031 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $577.30, for a total transaction of $1,749,796.30. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $203,786.90. This represents a 89.57% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now owns 473 shares in the company, valued at $271,397.94. The trade was a 63.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 30,111 shares of company stock worth $15,364,055 over the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.